Clinical Trials Directory

Trials / Unknown

UnknownNCT00421265

Active Surveillance for Prostate Cancer With Indolent Features

Prospective Cohort Study of Active Surveillance for Prostate Cancer With Indolent Linical Features

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (planned)
Sponsor
Assaf-Harofeh Medical Center · Other Government
Sex
Male
Age
65 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In patients with prostate cancer with indolent features, disease progrssion may be very slow and in many cases will never become clinically evident during the patient's lifetime. Active surveillance is a continuous process of monitoring disease characteristcs aiming to avoid the morbidity of active therapy in patients with stabe indolent parameters, while offering early detection of disease activity in others who will need active therapy to control their disease. We hypothesize that active surveillance will permit the avoidance of therapy related morbidity in the majority of appropriate patients and will be associated with maintaining their quality of life.

Conditions

Timeline

First posted
2007-01-11
Last updated
2007-01-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00421265. Inclusion in this directory is not an endorsement.

Active Surveillance for Prostate Cancer With Indolent Features (NCT00421265) · Clinical Trials Directory